Further rationale for optimal combined modality treatments

被引：0
|
作者：
Griffin, Robert J. [1 ]
Dings, Ruud P. M. [1 ]
Makhoul, Issam [1 ]
机构：
[1] Univ Arkansas Med Sci, Dept Radiat Oncol, Radiat Biol Div, Little Rock, AR 72205 USA
来源：
ONCOTARGET | 2017年 / 8卷 / 16期
关键词：
radiotherapy; anti-angiogenic agent; sunitinib; re-oxygenation; THERAPY; RADIATION; TUMORS;
D O I：
10.18632/oncotarget.16117
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：25831 / +
页数：2
相关论文
共 50 条
  • [31] ACNE-VULGARIS - TREATMENTS AND THEIR RATIONALE
    PUISSEGURLUPO, ML
    [J]. POSTGRADUATE MEDICINE, 1985, 78 (07) : 76 - &
  • [32] Rationale for early intervention with immunomodulatory treatments
    Tintore, Mar
    [J]. JOURNAL OF NEUROLOGY, 2008, 255 (Suppl 1) : 37 - 43
  • [33] FUTURE OF COMBINED MODALITY THERAPY
    DURANT, JR
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1981, 7 (06): : 783 - 790
  • [34] Combined modality therapy of esthesioneuroblastoma
    McLean, J. Nicolas
    Nunley, Sunjay R.
    Klass, Carmen
    Moore, Charles
    Mueller, Susan
    Johnstone, Peter A. S.
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2007, 136 (06) : 998 - 1002
  • [35] Combined modality therapy in NSCLC
    Eberhardt, W
    Bildat, S
    Korfee, S
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 85 - 95
  • [36] THE COMBINED MODALITY APPROACH TO CANCER
    OSIEKA, R
    SCHMIDT, CG
    [J]. LANGENBECKS ARCHIV FUR CHIRURGIE, 1983, 361 : 513 - 518
  • [37] Combined modality therapy for NSCLC
    Jassem, Jacek
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S272 - S274
  • [38] RATIONALE FOR OPTIMAL REACTOR DESIGN
    RAY, WH
    ARIS, R
    [J]. INDUSTRIAL & ENGINEERING CHEMISTRY FUNDAMENTALS, 1966, 5 (04): : 478 - &
  • [39] THE RATIONALE AND MANAGEMENT OF COMBINED THERAPY
    LACEY, BW
    [J]. BRITISH MEDICAL BULLETIN, 1960, 16 (01) : 42 - 46
  • [40] Rationale for oncological surgery in multimodal cancer treatments
    Elias, D
    [J]. JOURNAL DE CHIRURGIE, 2005, 142 (05): : 284 - 290
12345